ReadR


Discover Content : Trends

Discover real-time trending topics, hashtags, and content from different countries.


Headline : How GLP-1 Drug Success Transforms Healthcare Revenue – Is your Organization Ready?

Read more from the original article on here at feedpress.me.




Tags : #glp1 #drug #success #transforms #healthcare #revenue #your #organization #ready



No. of Paragraph 15

The huge revenue opportunity stemming from recent success of GLP-1 drugs is not just for the pharmaceutical companies. Is your healthcare organization poised to capture the patient care opportunity emerging from GLP-1 pharmaceutical innovation?

The new category of Diabetes, weight loss and obesity drugs called GLP-1s is predicted to be a game-changing innovation in population health management of some chronic disease types.  These drugs have shown tremendous success in treating their target diseases of Diabetes and Obesity, and adoption by patients continues to grow. The 42nd annual J.P. Morgan healthcare conference in San Francisco this month gave considerable coverage to this topic and to the group of pharmaceutical companies at the core of this unparalleled movement in reducing population health issues around diabetes and weight. Drugs such as Wegovy, Mounjaro and Ozempic are currently the most highly in demand and many patients are having trouble finding supply as a result of the accelerating adoption and approvals for use. But innovation in pharma can create opportunity in other areas, and this one is already doing just that for hospitals, clinics and ACOs in the healthcare industry.

Chris Schott, JP Morgan Sr. Analyst covering US Diversified Biopharma says the revenue opportunity for the pharma sector could be as much as $100B as we approach 2030 which would make it the largest therapeutic market they have ever seen.  He further predicts the capacity for GLP-1s to double in 2024 and increase another 50% in 2025, alleviating bottlenecks from a capacity standpoint. (1)

Lisa Gill, JP Morgan Sr. Analyst covering Healthcare services says things to watch are policies around coverage of these drugs. They are not currently covered by Medicaid or Medicare and should that change, volumes would likely be impacted even further. (2)

Read more from the original article on here at feedpress.me.


Related Headlines : How GLP-1 Drug Success Transforms Healthcare Revenue – Is your Organization Ready? (in Google.com):

Hello, below you have a "Web" tab to read more content and an "Image" tab to get related pictures

Example : Trends, Country, News, Jobs, Scholarships, Investment, Business, Politics, Adverts, Fashion, Events, Technology and more.